sur PHAXIAM THERAPEUTICS (isin : FR001400K4B1)
PHAXIAM announces the terms and conditions for making preparatory documents available for the Combined General Meeting
PHAXIAM Therapeutics has announced the terms and conditions for making preparatory documents available for the Combined General Meeting of June 28, 2024. The event will be held at 9:30 a.m. at the head office located 60 avenue Rockefeller in Lyon.
Shareholders can participate by attending the Meeting, by voting remotely via Votaccess or by giving a proxy. The documents, including the agenda and resolutions, are available on the company's website.
The notice of meeting and the notice of meeting were published in the Bulletin des Annonces Légales et Obligatoires respectively on May 22 and June 7, 2024.
PHAXIAM continues to keep shareholders informed via the dedicated section on its site, which will be updated according to legal requirements.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de PHAXIAM THERAPEUTICS